SEC 13F Intelligence

Xponance LLC / MRK

Xponance LLC’s Merck & Co Inc Position

Does Xponance LLC own Merck & Co Inc (MRK)? Yes473.1K shares worth $57M (+0.40% of its 13F portfolio) as of Q1 2026, up from 413.2K shares the prior filed quarter.

Position Value
$57M
Q1 2026
Shares
473.1K
% of Portfolio
+0.40%
Quarters Held
24
currently held

Position History MRK

Reported value by quarter
Q2 ’20: $38MQ2 ’20Q3 ’20: $38MQ4 ’20: $38MQ1 ’21: $35MQ1 ’21Q2 ’21: $12MQ3 ’21: $10MQ4 ’21: $15MQ4 ’21Q1 ’22: $17MQ2 ’22: $31MQ3 ’22: $33MQ3 ’22Q4 ’22: $47MQ1 ’23: $46MQ2 ’23: $44MQ2 ’23Q3 ’23: $40MQ4 ’23: $45MQ1 ’24: $53MQ1 ’24Q2 ’24: $73MQ3 ’24: $66MQ4 ’24: $60MQ4 ’24Q1 ’25: $56MQ2 ’25: $34MQ3 ’25: $35MQ3 ’25Q4 ’25: $43MQ1 ’26: $57Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026473.1K$57M+0.40%
Q4 2025413.2K$43M+0.33%
Q3 2025411.1K$35M+0.27%
Q2 2025430.8K$34M+0.28%
Q1 2025626.5K$56M+0.54%
Q4 2024603.6K$60M+0.55%
Q3 2024585.1K$66M+0.64%
Q2 2024591.4K$73M+0.75%
Q1 2024402.2K$53M+0.56%
Q4 2023412.6K$45M+0.54%
Q3 2023384.1K$40M+0.54%
Q2 2023378.2K$44M+0.58%
Q1 2023436.8K$46M+0.68%
Q4 2022423.8K$47M+0.76%
Q3 2022382.5K$33M+0.63%
Q2 2022341.2K$31M+0.62%
Q1 2022204.0K$17M+0.28%
Q4 2021199.3K$15M+0.24%
Q3 2021131.1K$10M+0.19%
Q2 2021154.5K$12M+0.22%
Q1 2021459.3K$35M+0.75%
Q4 2020461.0K$38M+0.82%
Q3 2020458.2K$38M+0.93%
Q2 2020485.2K$38M+0.97%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Xponance LLC’s full portfolio or all institutional holders of MRK.